EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Type I Interferon Drives a Cellular State Inert to TCR‐Stimulation and Could Impede Effective T‐Cell Differentiation in Cancer

Dillon Corvino iD, Martin Batstone, Brett G M Hughes, Tim Kempchen iD, Susanna S Ng, Nazhifah Salim iD, Franziska Schneppenheim, Denise Rommel, Ananthi Kumar, Sally Pearson, Jason Madore, Lambross T Koufariotis und 7 weitere

European Journal of Immunology · 2025

DOI: 10.1002/eji.202451371 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Immunology, 2025. Verfasst von Dillon Corvino und 18 weiteren Autor:innen. Beteiligte Einrichtung: Tumor-Immunobiology, Institute for Experimental Oncology, University Hospital Bonn, Bonn, Germany. Hauptthemen laut MEDLINE: CD8-Positive T-Lymphocytes, Interferon Type I, Lymphocytes, Tumor-Infiltrating, Head and Neck Neoplasms. Die Arbeit nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft (DFG, German Research Foundation), DFG Excellence Strategy, Melanoma Research Alliance.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Head and neck squamous cell carcinoma (HNSCC) is linked to human papillomavirus (HPV) infection. HPV‐positive and HPV‐negative HNSCC exhibit distinct molecular and clinical characteristics. Although checkpoint inhibitors have shown efficiency in recurrent/metastatic HNSCC, response variability persists regardless of HPV status. This study aimed to explore the CD8 + T‐cell landscape in HPV‐negative HNSCC.

Methods

We performed simultaneous single‐cell RNA and TCR sequencing of CD8 + tumor‐infiltrating lymphocytes (TILs) from treatment‐naïve HPV‐negative HNSCC patients. Additionally, cells were stimulated ex vivo, which allowed for the tracking of clonal transcriptomic responses.

Results

Our analysis identified a subset of CD8 + TILs highly enriched for interferon‐stimulated genes (ISG). TCR analysis revealed ISG cells are clonally related to a population of granzyme K (GZMK)‐expressing cells. However, unlike GZMK cells, which exhibited rapid effector‐like phenotypes following stimulation, ISG cells were transcriptionally inert. Additionally, ISG cells showed specific enrichment within tumor and were found across multiple tumor entities.

Conclusions

ISG‐enriched CD8 + TILs are a consistent feature of various tumor entities. These cells are poorly understood but possess characteristics that may impact antitumor immunity. Understanding the unique properties and functionality of ISG cells could offer innovative treatment approaches to improve patient outcomes in HPV‐negative HNSCC and other cancer types.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CD8-Positive T-LymphocytesInterferon Type ILymphocytes, Tumor-InfiltratingHead and Neck NeoplasmsReceptors, Antigen, T-CellSquamous Cell Carcinoma of Head and NeckHumansCell DifferentiationLymphocyte ActivationFemalePapillomavirus InfectionsMaleSingle-Cell Analysis

Stichwörter der Autor:innen

CD8+ T‐cellsHNSCC TILsType I IFNscRNAseqscTCRseq

Substanzen

Interferon Type IReceptors, Antigen, T-Cell

Autor:innen und Institutionen

  • Tumor-Immunobiology, Institute for Experimental Oncology, University Hospital Bonn, Bonn, Germany.
  • Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia.
  • Faculty of Medicine, University of Queensland, Brisbane, Queensland, Australia.
  • QIMR Berghofer Medical Research Institute, Herston, Australia.
  • Faculty of Mathematics and Natural Sciences, and the Life and Medical Sciences Institute (LIMES), Rheinische Friedrich-Wilhelms-Universität Bonn, Bonn, Germany.
  • Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, Missouri, USA.

ORCID-Profile: Dillon Corvino, Tim Kempchen, Nazhifah Salim

Förderung

  • Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)
  • DFG Excellence Strategy
  • Melanoma Research Alliance

Zitieren

APA

Corvino, D., Batstone, M., Hughes, B. G. M., Kempchen, T., Ng, S. S., Salim, N., Schneppenheim, F., Rommel, D., Kumar, A., Pearson, S., Madore, J., Koufariotis, L. T., Steinheuer, L. M., Pathirana, D., Thurley, K., Hölzel, M., Borcherding, N., Braun, M., & Bald, T. (2025). Type I Interferon Drives a Cellular State Inert to TCR‐Stimulation and Could Impede Effective T‐Cell Differentiation in Cancer. European Journal of Immunology. https://doi.org/10.1002/eji.202451371

Vancouver

Corvino D, Batstone M, Hughes BGM, Kempchen T, Ng SS, Salim N, et al. Type I Interferon Drives a Cellular State Inert to TCR‐Stimulation and Could Impede Effective T‐Cell Differentiation in Cancer. European Journal of Immunology. 2025. doi:10.1002/eji.202451371

BibTeX
@article{Corvino2025,
  author = {Corvino, Dillon and Batstone, Martin and Hughes, Brett G M and Kempchen, Tim and Ng, Susanna S and Salim, Nazhifah and Schneppenheim, Franziska and Rommel, Denise and Kumar, Ananthi and Pearson, Sally and Madore, Jason and Koufariotis, Lambross T and Steinheuer, Lisa Maria and Pathirana, Dilan and Thurley, Kevin and Hölzel, Michael and Borcherding, Nicholas and Braun, Matthias and Bald, Tobias},
  title = {Type I Interferon Drives a Cellular State Inert to TCR‐Stimulation and Could Impede Effective T‐Cell Differentiation in Cancer},
  journal = {European Journal of Immunology},
  year = {2025},
  doi = {10.1002/eji.202451371}
}
Kostenlos starten →